OP0068 Three Treatment Strategies in Recent Onset DMARD Naïve Juvenile Idiopathic Arthritis: Initial Results of the Best for Kids-Study

BackgroundIn the BeSt for Kids (a three-armed treatment strategy study in juvenile idiopathic arthritis (JIA)) time to inactive disease, time to flare after Disease Modifying Anti Rheumatic Drug (DMARD) discontinuation, ACRpedi scores, functional ability, safety, and radiological damage are compared...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.94-94
Hauptverfasser: Hissink Muller, P., Brinkman, D.M., Schonenberg, D., Koopman-Keemink, Y., van den Berg, J.M., Bekkering, P., van Rossum, M., van Suijlekom-Smit, L.W., Allaart, C.F., ten Cate, R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundIn the BeSt for Kids (a three-armed treatment strategy study in juvenile idiopathic arthritis (JIA)) time to inactive disease, time to flare after Disease Modifying Anti Rheumatic Drug (DMARD) discontinuation, ACRpedi scores, functional ability, safety, and radiological damage are compared. Follow up will be 2 years. Here we present the 3 months clinical outcomes of initial treatments.MethodsRecent onset, DMARD naïve JIA patients (Rheumatoid Factor-negative polyarticular, oligoarticular or with psoriasis (ILAR-criteria),
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2015-eular.2048